The 5-HT3 Receptor Antagonist Aloxi(R) Launched in Japan

LUGANO, Switzerland and TOKYO, Japan, April 22, 2010 – Helsinn Healthcare SA, Switzerland, and Taiho Pharmaceutical Co., Ltd.,
Japanese licensee of Helsinn's second generation 5-HT3 receptor antagonist
palonosetron, announce the launch of Aloxi(R) injection today.

Aloxi was developed in Japan by Taiho in close cooperation
with Helsinn, based on the license agreement between Taiho [...]

Innovative Technology Could Transform Women’s Health Across Europe

Non-Invasive Treatment for Uterine Fibroids (Myoma) Given Special Recognition at the German Federal Chancellery

TIRAT CARMEL, Israel, April 22, 2010 – The ExAblate(R) 2000, a magnetic resonance guided focus ultrasound
system, received special recognition by being included in the 10th nationwide
Girls' Day in Germany. This event held on April 21st, 2010 at the German
Federal Chancellery, celebrates [...]

Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors

NEW YORK, LONDON and HAMILTON, Bermuda, April 22, 2010 – Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today announced the
initiation of a Phase I/II pediatric dose tolerance trial to test their
investigational new drug XERECEPT(R) in pediatric patients suffering from
primary, recurrent or metastatic brain tumors.

Celtic Pharma's objective for this trial is to [...]

Exeter(R) Hip System Celebrates 40th Anniversary and Manufacture of One-Millionth Hip Stem

Surgeon-Created Orthopaedic Hip System Revolutionized Hip Implant Design, Continues to Deliver Excellent Clinical Results

EXETER, England, April 22, 2010 – Stryker Corporation's Orthopaedics Division is celebrating this month the
one-millionth manufacturing of its Exeter hip stem (
www.exeterhip.co.uk), an implant developed in collaboration with an
orthopaedic surgeon and engineer to address the problem of aseptic loosening.
This year also [...]

El Instituto Palacios acogera en Espana a becarios de Master en Climaterio y Menopausia para potenciar su formacion en Salud de la Mujer

Master en Climaterio y Menopausia, un proyecto 100% online, cuenta con el respaldo de la FLASCYM, la IMS, el CAMS, la Asociacion Espanola para el Estudio de la Menopausia (AEEM) y los especialistas de mayor prestigio internacional

MADRID, April 22, 2010 – Master en Climaterio y Menopausia(R), una iniciativa que nace
con el objetivo de dar [...]

Amira Pharmaceuticals Announces Patent Grant in United Kingdom

Patent Covers Novel DP2 (CRTH2) Receptor Antagonists for the Treatment of Respiratory Disorders

SAN DIEGO, April 22, 2010 – Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual
Property Office has granted it patent number GB2460597
(www.ipo.gov.uk/p-find-publication-result?PatentNo=GB2460597&Journal
Number=0&EarliestYear=1900&EarliestWeek=1&LatestYear=2050&LatestWeek=52&Doc
Types=A%2CA8%2CA9%2CB%2CB8%2CC%2CC2%2CC3&ResultsPerPage=2&Start=0 ) titled
"N,N-Disubstituted aminoalkylBiPhenyl Antagonists OF Prostaglandin d2
RECEPTORS."
This is the first patent granted of a large estate [...]

Colorcon Acquires Pharmaceutical Excipient Company – NP Pharm

HARLEYSVILLE, Pennsylvania, April 22, 2010 – Colorcon, Inc. today announced the acquisition of the full-service
pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This
acquisition expands Colorcon's global excipient product offerings in the
pharmaceutical and nutritional markets.

The addition of NP Pharm SUGLETS(R) sugar spheres complements Colorcon's
SureSpheres(R) sugar spheres product line and barrier [...]